Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Reduced-Dose Ibrutinib Is Well Tolerated and Cost Effective for the Treatment of Chronic Lymphocytic Leukemia in Frail Older Adults

Arashpreet Chhina, Monica Pernia Marin, Shrina P Thomas, Elizabeth G Vallejo, Kathryn Cappell, Maneesh Jain

Blood (2021) 138 (Supplement 1): 4967.

https://doi.org/10.1182/blood-2021-154246

Published: 2021

Journal Articles

Reduced-Dose Venetoclax Is Well Tolerated and Cost Effective for the Treatment of Chronic Lymphocytic Leukemia in Frail Older Adults

Monica Pernia Marin, Malak Alharbi, Arashpreet Chhina, Shrina P Thomas, Maneesh Jain

Blood (2021) 138 (Supplement 1): 4968.

https://doi.org/10.1182/blood-2021-154487

Published: 2021

Journal Articles

Phase II Study of Temsirolimus and Lenalidomide in Patients with Relapsed and Refractory Lymphomas: Final Analysis of NCI 8309

Justin Kline, MD, Aaron P. Rapoport, MD, Adam M. Petrich, MD, Kenneth S. Cohen, MD, Sachdev P. Thomas, MD, Sreenivasa Nattam, MD, Krishna Rao, MD, Bethany Sleckman, MD, Walter Stadler, MD, Theodore Karrison, PhD, Sonali M. Smith, MD

Blood (2016) 128 (22): 4147.

https://doi.org/10.1182/blood.V128.22.4147.4147

Published: 2016

Journal Articles

Connect MM®—the Multiple Myeloma (MM) Disease Registry: Incidence of Second Primary Malignancies (SPM)

Robert M. Rifkin, MD, Rafat Abonour, MD, Jatin J. Shah, MD, Jayesh Mehta, MD, Mohit Narang, MD, Howard R. Terebelo, DO, Cristina J Gasparetto, MD, Sachdev P. Thomas, MD, Kathleen Toomey, MD, James W Hardin, PhD, Jane Jie Lu, MS, Laurie Kenvin, BSN, RN, Shankar Srinivasan, PhD, Rosanna J. Ricafort, MD, Yasir Nagarwala, MD, Brian G. M. Durie, MD

Blood (2014) 124 (21): 4749.

https://doi.org/10.1182/blood.V124.21.4749.4749

Published: 2014

Journal Articles

Connect MM ® —the Multiple Myeloma (MM) Disease Registry: Interim Analysis of Overall Survival and Outcomes in Patients with High-Risk Disease

Jatin J. Shah, MD, Rafat Abonour, MD, Brian G M Durie, MD, Jayesh Mehta, MD, Mohit Narang, MD, Howard Terebelo, DO, Cristina J Gasparetto, MD, Sachdev P. Thomas, MD, Kathleen Toomey, MD, James W Hardin, PhD, Shankar Srinivasan, PhD, Rosanna J. Ricafort, MD, Yasir Nagarwala, MD, Robert M. Rifkin, MD

Blood (2014) 124 (21): 2106.

https://doi.org/10.1182/blood.V124.21.2106.2106

Published: 2014

Journal Articles

Response To First-Line Treatment In Stem Cell Transplant (SCT) and Non-SCT Patients With Newly Diagnosed Multiple Myeloma Who Are Enrolled In The Connect MM Registry

Rafat Abonour, MD, Jatin J. Shah, M.D., Brian Durie, MD, Howard Terebelo, DO, Cristina J Gasparetto, MD, Jayesh Mehta, MD, Mohit Narang, MD, Sachdev P Thomas, MD, Kathleen Toomey, MD, Kristen A Sullivan, MBA, CCRA, Shankar Srinivasan, PhD, Yasir Nagarwala, MD, Robert M Rifkin, MD

Blood (2013) 122 (21): 3207.

https://doi.org/10.1182/blood.V122.21.3207.3207

Published: 2013

Journal Articles

Pluripotent Fibrosis Initiating Mesenchymal Stromal Cell Linked To Cytopenias In LGL Leukemia Through Genetic Reprogramming

Pearlie K. Epling-Burnette, PhD, Adam W. Mailloux, PhD, Ling Zhang, MD, Lynn C. Moscinski, MD, Sheng Wei, MD, Sean J Yoder, MS, Lubomir Sokol, MD, Ph.D, Loughran P Thomas, MD

Blood (2013) 122 (21): 1218.

https://doi.org/10.1182/blood.V122.21.1218.1218

Published: 2013

Journal Articles

Esterified eicosanoids are acutely generated by 5-lipoxygenase in primary human neutrophils and in human and murine infection

Stephen R. Clark, Christopher J. Guy, Martin J. Scurr, Philip R Taylor, Ann P. Kift-Morgan, Victoria J. Hammond, Christopher P. Thomas, Barbara Coles, Gareth W. Roberts, Matthias Eberl, Simon A. Jones, Nicholas Topley, Sailesh Kotecha, Valerie B. O'Donnell

Blood (2011) 117 (6): 2033–2043.

https://doi.org/10.1182/blood-2010-04-278887

Published: 2011

Includes: Supplemental data

Journal Articles

MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-κB–dependent lymphoma

Michael A. Milhollen, Tary Traore, Jennifer Adams-Duffy, Michael P. Thomas, Allison J. Berger, Lenny Dang, Lawrence R. Dick, James J. Garnsey, Erik Koenig, Steven P. Langston, Mark Manfredi, Usha Narayanan, Mark Rolfe, Louis M. Staudt, Teresa A. Soucy, Jie Yu, Julie Zhang, Joseph B. Bolen, Peter G. Smith

Blood (2010) 116 (9): 1515–1523.

https://doi.org/10.1182/blood-2010-03-272567

Published: 2010

Includes: Supplemental data

Journal Articles

Phase II Study of the Oral MEK Inhibitor AZD6244 in Advanced Acute Myeloid Leukemia (AML).

Blood (2009) 114 (22): 2081.

https://doi.org/10.1182/blood.V114.22.2081.2081

Published: 2009

Journal Articles

Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells

Rainer Wiewrodt, Anu P. Thomas, Luca Cipelletti, Melpo Christofidou-Solomidou, David A. Weitz, Sheldon I. Feinstein, David Schaffer, Steven M. Albelda, Michael Koval, Vladimir R. Muzykantov

Blood (2002) 99 (3): 912–922.

https://doi.org/10.1182/blood.V99.3.912

Published: 2002

Journal Articles

CD148 Is a Membrane Protein Tyrosine Phosphatase Present in All Hematopoietic Lineages and Is Involved in Signal Transduction on Lymphocytes

Miguel Angel de la Fuente-Garcı́a, Josep Maria Nicolás, John H. Freed, Eduard Palou, Andrew P. Thomas, Ramón Vilella, Jordi Vives, Antoni Gayá

Blood (1998) 91 (8): 2800–2809.

https://doi.org/10.1182/blood.V91.8.2800.2800_2800_2809

Published: 1998

Journal Articles

T lymphocyte growth factor as a regulatory molecular for the growth and function of T lymphocytes [letter]

PG de LaForest, P Thomas, F Guilhot, F Triebel, MD Mossalayi, J Tanzer

Blood (1982) 59 (5): 1110–1111.

https://doi.org/10.1182/blood.V59.5.1110.1110

Published: 1982

NARROW

Reduced-Dose Ibrutinib Is Well Tolerated and Cost Effective for the Treatment of Chronic Lymphocytic Leukemia in Frail Older Adults

Reduced-Dose Venetoclax Is Well Tolerated and Cost Effective for the Treatment of Chronic Lymphocytic Leukemia in Frail Older Adults

Phase II Study of Temsirolimus and Lenalidomide in Patients with Relapsed and Refractory Lymphomas: Final Analysis of NCI 8309

Connect MM®—the Multiple Myeloma (MM) Disease Registry: Incidence of Second Primary Malignancies (SPM)

Connect MM ® —the Multiple Myeloma (MM) Disease Registry: Interim Analysis of Overall Survival and Outcomes in Patients with High-Risk Disease

Response To First-Line Treatment In Stem Cell Transplant (SCT) and Non-SCT Patients With Newly Diagnosed Multiple Myeloma Who Are Enrolled In The Connect MM Registry

Pluripotent Fibrosis Initiating Mesenchymal Stromal Cell Linked To Cytopenias In LGL Leukemia Through Genetic Reprogramming

Esterified eicosanoids are acutely generated by 5-lipoxygenase in primary human neutrophils and in human and murine infection

MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-κB–dependent lymphoma

Phase II Study of the Oral MEK Inhibitor AZD6244 in Advanced Acute Myeloid Leukemia (AML).

Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells

CD148 Is a Membrane Protein Tyrosine Phosphatase Present in All Hematopoietic Lineages and Is Involved in Signal Transduction on Lymphocytes

T lymphocyte growth factor as a regulatory molecular for the growth and function of T lymphocytes [letter]

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only